AR038405A1 - Gen de streptomyces avermitilis que rige la relacion de avermectinas b2:b1 - Google Patents

Gen de streptomyces avermitilis que rige la relacion de avermectinas b2:b1

Info

Publication number
AR038405A1
AR038405A1 ARP030100408A ARP030100408A AR038405A1 AR 038405 A1 AR038405 A1 AR 038405A1 AR P030100408 A ARP030100408 A AR P030100408A AR P030100408 A ARP030100408 A AR P030100408A AR 038405 A1 AR038405 A1 AR 038405A1
Authority
AR
Argentina
Prior art keywords
avermitilis
avec
avermectins
class
ratio
Prior art date
Application number
ARP030100408A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR038405A1 publication Critical patent/AR038405A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/623Avermectin; Milbemycin; Ivermectin; C-076

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
ARP030100408A 2002-02-12 2003-02-10 Gen de streptomyces avermitilis que rige la relacion de avermectinas b2:b1 AR038405A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35622202P 2002-02-12 2002-02-12

Publications (1)

Publication Number Publication Date
AR038405A1 true AR038405A1 (es) 2005-01-12

Family

ID=27734621

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030100408A AR038405A1 (es) 2002-02-12 2003-02-10 Gen de streptomyces avermitilis que rige la relacion de avermectinas b2:b1

Country Status (25)

Country Link
US (2) US7388085B2 (enExample)
EP (2) EP2050815B1 (enExample)
JP (1) JP2005517406A (enExample)
KR (1) KR100718378B1 (enExample)
CN (2) CN1630712B (enExample)
AR (1) AR038405A1 (enExample)
AT (2) ATE530645T1 (enExample)
AU (1) AU2003245052B2 (enExample)
BR (1) BRPI0307620B8 (enExample)
CA (1) CA2475214C (enExample)
CY (2) CY1110454T1 (enExample)
DE (1) DE60326824D1 (enExample)
DK (2) DK1476539T3 (enExample)
ES (2) ES2373629T3 (enExample)
IL (3) IL162866A0 (enExample)
ME (1) ME00472B (enExample)
MX (1) MXPA04007777A (enExample)
PL (1) PL211693B1 (enExample)
PT (2) PT1476539E (enExample)
RS (1) RS50813B (enExample)
RU (1) RU2293117C2 (enExample)
SI (2) SI1476539T1 (enExample)
TW (1) TWI341330B (enExample)
WO (1) WO2003068955A2 (enExample)
ZA (1) ZA200405345B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE530645T1 (de) * 2002-02-12 2011-11-15 Pfizer Prod Inc Streptomyces avermitilis gen zur regulierung des verhältnisses der b2:b1 avermectine
CN102241750B (zh) * 2010-05-14 2014-05-28 中国科学院微生物研究所 一种生产阿维菌素的基因工程方法及其专用菌株
CN102093997B (zh) * 2010-12-01 2013-03-13 中国科学院上海有机化学研究所 一种改造除虫链霉菌产生多拉菌素的方法
CN109576196B (zh) * 2019-01-25 2022-01-04 北大方正集团有限公司 一种生产多拉菌素的发酵培养基及多拉菌素的生产方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE434277B (sv) 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4429042A (en) 1978-09-08 1984-01-31 Merck & Co., Inc. Strain of Streptomyces for producing antiparasitic compounds
IN167980B (enExample) 1987-01-23 1991-01-19 Pfizer
US5252474A (en) 1989-03-31 1993-10-12 Merck & Co., Inc. Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use
AU680039B2 (en) * 1993-10-05 1997-07-17 Pfizer Inc. Process and antiparasitic intermediates for doramectin
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
JP2002503473A (ja) * 1998-02-13 2002-02-05 ファイザー・プロダクツ・インク B2:b1アベルメクチンの比に関するストレプトミセス・アベルミティリス遺伝子
US6248579B1 (en) * 1998-02-13 2001-06-19 Pfizer Inc Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
RU2156301C2 (ru) * 1998-06-09 2000-09-20 Мосин Владимир Александрович Штамм актиномицета streptomyces avermitilis ссм 4697 - продуцент авермектинов
US6197591B1 (en) 1998-09-14 2001-03-06 Pfizer Inc. Streptomyces avermitilis regulatory genes for increased avermectin production
PT1200606E (pt) * 1999-08-12 2006-12-29 Pfizer Prod Inc Gene de streptomyces avermitilis que regula a proporção de avermectinas b2:b1
AR032130A1 (es) 1999-08-13 2003-10-29 Vertex Pharma Un compuesto inhibidor de quinasas proteicas, una composicion farmaceutica que lo incluye, y un metodo para tratar afecciones con dicho compuesto
ATE530645T1 (de) * 2002-02-12 2011-11-15 Pfizer Prod Inc Streptomyces avermitilis gen zur regulierung des verhältnisses der b2:b1 avermectine

Also Published As

Publication number Publication date
ME00472B (me) 2011-10-10
DE60326824D1 (de) 2009-05-07
WO2003068955A3 (en) 2003-11-13
KR100718378B1 (ko) 2007-05-14
TWI341330B (en) 2011-05-01
PT1476539E (pt) 2009-04-09
PL211693B1 (pl) 2012-06-29
ATE530645T1 (de) 2011-11-15
EP1476539B1 (en) 2009-03-25
EP1476539A2 (en) 2004-11-17
CA2475214A1 (en) 2003-08-21
US7388085B2 (en) 2008-06-17
CY1112491T1 (el) 2015-12-09
BRPI0307620B1 (pt) 2015-08-11
BR0307620A (pt) 2004-12-07
CN102392028B (zh) 2013-08-14
IL162866A0 (en) 2005-11-20
DK1476539T3 (da) 2009-05-11
JP2005517406A (ja) 2005-06-16
ES2373629T3 (es) 2012-02-07
PT2050815E (pt) 2012-01-02
AU2003245052A1 (en) 2003-09-04
CN102392028A (zh) 2012-03-28
IL192371A (en) 2010-11-30
BRPI0307620B8 (pt) 2016-09-13
KR20040081199A (ko) 2004-09-20
HK1074644A1 (en) 2005-11-18
WO2003068955A2 (en) 2003-08-21
PL371320A1 (en) 2005-06-13
CA2475214C (en) 2012-07-31
MXPA04007777A (es) 2004-10-15
SI1476539T1 (sl) 2009-06-30
IL162866A (en) 2009-11-18
CN1630712A (zh) 2005-06-22
RS50813B (sr) 2010-08-31
SI2050815T1 (sl) 2012-01-31
RU2293117C2 (ru) 2007-02-10
ZA200405345B (en) 2005-06-14
RU2004124521A (ru) 2005-04-10
EP2050815A1 (en) 2009-04-22
CN1630712B (zh) 2011-09-28
AU2003245052B2 (en) 2008-07-31
ATE426659T1 (de) 2009-04-15
DK2050815T3 (da) 2011-12-12
IL192371A0 (en) 2008-12-29
ES2321827T3 (es) 2009-06-12
TW200303918A (en) 2003-09-16
US8008078B2 (en) 2011-08-30
US20090017508A1 (en) 2009-01-15
HK1168383A1 (en) 2012-12-28
US20030166165A1 (en) 2003-09-04
CY1110454T1 (el) 2015-04-29
EP2050815B1 (en) 2011-10-26
RS70004A (sr) 2006-10-27

Similar Documents

Publication Publication Date Title
Dobson et al. Phylogenetic analysis of the genus Pediococcus, including Pediococcus claussenii sp. nov., a novel lactic acid bacterium isolated from beer.
Yu et al. Bradyrhizobium ottawaense sp. nov., a symbiotic nitrogen fixing bacterium from root nodules of soybeans in Canada
AR103092A2 (es) Método para preparar una bacteria del género sphingomonas que comprende una mutación, una cepa mutante de sphingomonas, bacteria aislada y purificada, método para producir un polisacárido sphingan que comprende cultivar la bacteria, y caldo de cultivo que la comprende
Huang et al. Proposal to combine the genera Actinobispora and Pseudonocardia in an emended genus Pseudonocardia, and description of Pseudonocardia zijingensis sp. nov..
Baeza et al. Codon usage and codon context bias in Xanthophyllomyces dendrorhous
Lin et al. Genetic and chemical diversity of edible mushroom Pleurotus species
Zhou et al. Identification and genetic characterization of Streptococcus iniae strains isolated from diseased fish in China.
Beurmann et al. Pseudoalteromonas piratica sp. nov., a budding, prosthecate bacterium from diseased Montipora capitata, and emended description of the genus Pseudoalteromonas
Martínez-Checa et al. Alteromonas hispanica sp. nov., a polyunsaturated-fatty-acid-producing, halophilic bacterium isolated from Fuente de Piedra, southern Spain
HUP0100177A2 (hu) Növelt mennyiségű szacharózt tartalmazó, keményítő nélküli Pisum sativum változat
AR038405A1 (es) Gen de streptomyces avermitilis que rige la relacion de avermectinas b2:b1
Zhang et al. Genome evolution trend of common carp (Cyprinus carpio L.) as revealed by the analysis of microsatellite loci in a gynogentic family
Busse et al. Classification of three corynebacterial strains isolated from the Northern Bald Ibis (Geronticus eremita): proposal of Corynebacterium choanae sp. nov., Corynebacterium pseudopelargi sp. nov., and Corynebacterium gerontici sp. nov.
Sheu et al. Tenacibaculum litopenaei sp. nov., isolated from a shrimp mariculture pond
CO5290296A1 (es) Gen de streptomyces avermitilis que dirige la relacion de avermectinas b2:b1
PE20010690A1 (es) Gen de streptomyces avermitilis que dirige la relacion de avermectinas b2:b1
CO5070698A1 (es) Gen de streptomyces avermitilis que dirige la relacion de avermectinas b2:b1
Brevik et al. Multiple-locus, variable number of tandem repeat analysis (MLVA) of the fish-pathogen Francisella noatunensis
Mahmoud et al. Litoribacterium kuwaitense gen. nov., sp. nov., isolated from a Kuwait tidal flat
Song et al. Aurantimonas marina sp. nov., isolated from deep-sea sediment
Fontebasso Improving strategies to develop anti-Candida treatments based on the vaginal species L. gasseri: from molecular approaches to physiological analyses.
Yeon et al. Organization of three rRNA (rrn) operons from Sphingobium chungbukense DJ77
Busse Birgit Huber, Raquel Escudero, 2 Hans-Jurgen Busse, Erik Seibold, 3 Holger C. Scholz, 3 Pedro Anda, 2 Peter Kampfer4 and Wolf D. Splettstoesser3

Legal Events

Date Code Title Description
FG Grant, registration